CS logo
small CS logo
Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department

Istanbul, Turkey
İstanbul'da bir tam teşekküllü hastane

About Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department


"Kartal Dr. Lütfi Kırdar Şehir Hastanesi"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Janssen Pharmaceutica N.V., Belgium
1
Janssen Research & Development, LLC
1
Total Rows: 3

Clinical Trials at Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department


During the past decade, Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2211331100110011Started TrialsCompleted Trails201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-12-27
2024-12-31
Active, not recruiting
438
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
2019-08-01
2022-09-19
Completed
3,679
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
2020-01-29
2025-09-19
Recruiting
400
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants
2020-11-12
2030-01-28
Recruiting
412
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
2020-11-27
2023-11-27
Active, not recruiting
303

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7Janssen PharmaceuticaN.V., Belgium: 1Janssen PharmaceuticaN.V., Belgium: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1

Created with Highcharts 11.1.0Top CollaboratorsAlliance FoundationTrials (AFT): 1Alliance FoundationTrials (AFT): 1Breast International Group: 1Breast International Group: 1Frontier Science &Technology ResearchFoundation, Inc.: 1Frontier Science &Technology ResearchFoundation, Inc.: 1German Breast Group: 1German Breast Group: 1Institut JulesBordet/Clinical TrialsSupport Unit (IJB/CTSU):1Institut JulesBordet/Clinical TrialsSupport Unit (IJB/CTSU):1NSABP Foundation Inc: 1NSABP Foundation Inc: 1

Clinical Trials Conditions at Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department


According to Clinical.Site data, the most researched conditions in "Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department" are "Breast Cancer" (3 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials), "NSCLC" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department" in a lesser frequency.

Clinical Trials Intervention Types at Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department


Most popular intervention types in "Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department" are "Drug" (8 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Alectinib" (1 trials), "Apalutamide" (1 trials), "Archival Tumor Tissue Sample" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department


The vast majority of trials in "Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department" are 8 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department


Currently, there are NaN active trials in "Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kartal Dr Lutfi Kirdar Sehir Hastanesi; Medical Oncology Department, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 4Active, not recruiting: 4Recruiting: 3Recruiting: 3Completed: 2Completed: 2